Search

everythinglearnresearchcommunity

for

Search:↓

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Spironolactone did not make hair thinner in women with excess hair growth.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Hirsutism causes significant psychological distress in women.

A new mutation in the AGPAT2 gene causes severe fat tissue loss and related health issues by reducing the protein's levels.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Current research explores hair growth drugs, while future research aims for personalized treatments.